Gadgets News

The Rapid COVID test will soon be provided by insurance in the US

[ad_1]

It is a type of COVID-19 Omicron running in the US and elsewhere, experimentation is essential for work, school and recreation to continue. With fast testing tools, however, some retailers are making them less expensive by purchasing customers. Now, Biden officials have announced that test kits should be provided with private insurance, The Wall Street Journal they say.

People with health insurance can be reimbursed up to eight tests per month per person. To make things easier, the White House is urging insurers to partner with drug dealers and retailers so that people can get tested without having to pay in advance or pay interest. These tests are available without cancellation, coinsurance or refunds, so a family of four children with the same health plan can be reimbursed 32 exams per month, e.g. For such programs, the refund is only $ 12 per trial.

Current developments also remove financial barriers and increase access to the Covid-19 test for millions of people.

The new policy does not apply to Medicare, which counts more than 60 million adults who are at high risk for COVID-19 complications. However, Medicaid for low-income people have already tested the FDA-approved home-tested test of COVID-19. The government plans to provide tens of millions of free tests to Americans who do not have health insurance in hospitals and other facilities, according to The New York Times.

Some insurers said supervisors were too late and did not address the shortage of home exams. However, another international health agency said the new system “is working to reduce the real risks of cost, fraud and abuse.”

Having enough tests will be the key to reducing Omicron waves that are beginning to disrupt health systems in the US and elsewhere. It can help people living with HIV to isolate themselves or receive treatment more quickly, reducing the risk of infection and the increased demand for medical services.

This will be especially important when licensing for antiretroviral drugs Pfizer and Merck which can help high-risk patients with low levels of COVID – unless they are diagnosed with time. “The concept will help millions of families get a COVID test that allows them to stay in school, visit relatives and live their lives,” Sabrina Corlette of Georgetown University told reporters. WSJ.

All sales supported by Engadget are selected by our writing team, independent of our parent company. Some of our articles include links to links. When you purchase something through one of these links, we may be able to find a partner.

[ad_2]

Source link

Related Articles

Leave a Reply

Back to top button